Patients 18 to 85 years of age with open-angle glaucoma and progressive visual field defects under maximum tolerated medical therapy were randomized to undergo initial fornix-based trabeculectomy with MMC ( 0.2 mg/mL for 5 min ) with subconjunctival preparation of 66 mm ( group A ) or 89 mm ( group B ) .